Headlands Research to open de novo clinical trial site in Grand Rapids, Michigan

PUBT · 1d ago
Headlands Research to open de novo clinical trial site in Grand Rapids, Michigan
  • Headlands Research launched a de novo clinical trial site in Grand Rapids, Michigan, with an expected opening later this year.
  • Planned build-out targets Midwest capacity in rheumatology, autoimmune disease, bone and joint conditions, with added cardiometabolic trial work.
  • Site will be led by board-certified rheumatologist Eric Slavin, bringing Phase III-IV trial experience in rheumatoid arthritis therapies.
  • Expansion follows recent network growth via two California site acquisitions, now Headlands Research - Sacramento and Headlands Research - CTR-Lincoln.
  • Recent footprint additions also include a new clinical research site in Bellingham, Washington, operating as Headlands Research - Western Washington.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Headlands Research Inc. published the original content used to generate this news brief on September 10, 2026, and is solely responsible for the information contained therein.